EpiPen Prices, the Clinton Foundation, and Lead Exposure
Podcast: Explain It to MePublished On: Wed Aug 31 2016
Description: Why did EpiPen's price skyrocket 400 percent over the past decade? Sarah and Matt dive into the complex world of American drug pricing to find out. Also on this episode: understanding why the Clinton Foundation gets so much scrutiny, and a white paper of the week that shows how problematic a small level of lead exposure can be. Learn more about your ad choices. Visit podcastchoices.com/adchoices
The note was deleted
The note was saved
Your message was sent